Printer Friendly

Check for IgA deficiency in suspected celiac cases.

NEW YORK -- Serology tests for suspected celiac disease are often inappropriately ordered or managed, increasing the chance of missed diagnosis, according to a study presented at an international symposium on celiac disease.

An analysis of 349 positive antiendomysial antibody (EMA) tests over a 17-month period showed that 51% of patients had not received a concurrent serum IgA test to evaluate for IgA deficiency, and 10% of patients were overlooked for a follow-up intestinal biopsy, reported Kelly McGowan of the University of Calgary (Alta.).

IgA deficiency is more common in patients with celiac disease than in the general population, and its presence negates the results of EMA tests, according to Ms. McGowan. "The EMA tests were inappropriately ordered in the absence of IgA tests, because if a patient with IgA deficiency undergoes screening for celiac disease, their test result will always be negative."

Of the positive serology tests, 69% were appropriately managed with a follow-up intestinal biopsy. A total of 194 biopsies were diagnostic of celiac disease, yielding a positive predictive value of 91% and a disease prevalence of 2%, based on the total sample of 9,533 patients tested.

Another 8% of positive serology tests did not include a follow-up biopsy but were considered to be appropriately managed because a biopsy had been done previously or was contraindicated, she said.

A further 3% of patients refused a biopsy, and 5% of tests were not followed up because of an administrative error.

But 10% of tests were classified as inappropriately managed because physicians failed to order a biopsy. For another 5% of tests, the physicians did not respond to the investigator's query about why they did not order a biopsy, possibly representing more mismanaged tests, she said.


Montreal Bureau
COPYRIGHT 2007 International Medical News Group
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Gastroenterology; Immunoglobulin A
Author:Johnson, Kate
Publication:Internal Medicine News
Article Type:Brief article
Geographic Code:1U2NY
Date:Jan 1, 2007
Previous Article:Dental, oral clues can point to celiac disease.
Next Article:Natalizumab takes Crohn's remission Past 2 years.

Related Articles
Antibody tests can be helpful in diagnosing celiac disease.
Underdiagnosis of celiac disease continues.
Antibodies against synthetic deamidated gliadin peptides as predictors of celiac disease: prospective assessment in an adult population with a high...
Anti-transglutaminase antibody assay of the culture medium of intestinal biopsy specimens can improve the accuracy of celiac disease diagnosis.
Diagnostic accuracy of ten second-generation (human) tissue transglutaminase antibody assays in celiac disease.
Comparison of anti-transglutaminase ELISAs and an anti-endomysial antibody assay in the diagnosis of celiac disease: a prospective study.
Selective IgA deficiency and common variable immunodeficiency/ IgA eksikligi ve yaygin degisken immun yetmezlik.
Celiac disease is often underdiagnosed.
Celiac disease: the great masquerader.
Genetic risks influence diagnostic strategy in celiac disease.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters